BNET Industries
Digene Corp. is in the Pharma Industry
Latest News and Analysis
Digene Corp. of Gaithersburg reports strong sales
Digene Corp., of Gaithersburg, which makes gene-based diagnostic tests, said its fiscal third-quarter profit surged on strong sales of its human papillomavirus test in the United States. For the quarter ended March 31, earnings were $5.3 million, or 21 cents per share, up from $1.1 million, or 5 cents per...
Chief scientist Lorincz quits Gaithersburg-based Digene Corp.
Digene Corp. is losing its chief scientific officer, a renowned expert on human papillomavirus, the sexually transmitted infection for which the Gaithersburg firm makes the only approved diagnostic test.
News Summary
Digene's shares drop 6.3% Shares of Digene Corp., the Gaithersburg-based maker of a test for the virus that causes cervical cancer, on Tuesday fell the most in six months on prospects for increased competition. Shares sank by $2.75, or 6.3 percent, to $41.05 at 4 p.m. in Nasdaq...
'Call to Action' Will Accelerate Fight Against Cervical Cancer in Europe: Digene Corp.
BRUSSELS, Belgium, January 23 /PRNewswire/ -- The launch of the "Call to Action to Stop Cervical Cancer in Europe" will accelerate the fight to eradicate this fully preventable and deadly disease, Digene Corp. said today in announcing i BRUSSELS, Belgium, January 23...
Digene to Present at JPMorgan Healthcare Conference.
M2 PRESSWIRE-5 January 2007-Early Watch: Digene to Present at JPMorgan Healthcare ConferenceC1994-2007 M2 COMMUNICATIONS LTD RDATE:05012007 A leader in molecular diagnostics, Digene (NASDAQ:DIGE) develops, manufactures and markets proprietary DNA and RNA tests, with a focus on women's health. The company's flagship...
Digene Corp. of Gaithersburg names Daryl J. Faulkner its new CEO
Digene Corp., of Gaithersburg, a biotechnology company that manufactures and markets tests for women's cancers and infectious diseases, said Daryl J. Faulkner has been named as its new president and chief executive officer, effective Dec. 11. Faulkner, 57, succeeds current CEO Evan Jones, Digene's chairman and founder, who will continue...
Gaithresburg-based Digene Corp.'s drop in profits brings drop in
Digene Corp. of Gaithersburg reported mixed results for its fiscal third quarter, with a 32 percent increase in revenue over last year's comparable period, but a 31 percent drop in its net income.
Cash in hand, Gaithersburg-based Digene Corp. buys into new product
Gaithersburg-based Digene Corp. has embarked on a new business endeavor - the acquisition of marketing and distribution rights for diagnostic tests made by other firms.The company, known for its test for human papillomavirus, or HPV, yesterday announced an exclusive marketing and distribution agreement with Austin, Texas-based Asuragen Inc. for that...
Zacks Buy List Highlights: Digene Corporation, The Boeing Company, Leap Wireless International, Inc., and Southern Union Company
CHICAGO -- Zacks.com releases the latest list of Zacks Rank Buy Stocks. Everyday on Zacks.com, four stocks are selected based on how well they match the criteria for the four main schools of investing: Aggressive Growth, Growth & Income, Momentum and Value. The four Zacks Rank Buy stocks highlighted today...
Gaithersburg-based Digene Corp.'s HPV test gets boost in European
Gaithersburg-based Digene Corp. is touting a new study out of Europe showing that its human papillomavirus, or HPV, genetic test is more effective than the traditional cytology test, or Pap smear.The company's test for the high-risk variety of HPV, the virus that causes cervical cancer, has been approved since 2003...
Gaithersburg-based Digene Corp. stock priced
Digene Corp., of Gaithersburg, a biotechnology company that manufactures and markets tests for diseases afflicting primarily women, said it priced the previously announced public offering of 3 million shares of common stock at $28 per share. The offering will consist of 2 million shares of newly issued stock from Digene...
Gaithersburg-based Digene Corp., reports net income
Digene Corp., of Gaithersburg, a biotechnology company that manufactures and markets tests for diseases afflicting primarily women, reported net income for its fiscal first quarter ended Sept. 30 of $1.3 million, or 6 cents per diluted share, on revenue of $33.4 million, versus a net loss of $6.3 million, or...
Gaithersburg-based Digene Corp. offering HPV test
Digene Corp., of Gaithersburg, a biotechnology company that manufactures and markets tests for diseases afflicting primarily women, announced that DCL Medical Laboratories, a women's health- focused lab serving the Indianapolis and St. Louis areas, is offering its customers the Digene HPV Test for cervical cancer screening. This is the only...
MD-based Digene Corp. settles lawsuit for $7.5 million
Digene Corp. has settled a licensing dispute with Georgetown University that threatened to snatch away a key part of its cervical cancer screening tests, the company said yesterday.
Gaithersburg-based Digene Corp.'s profits drop
Digene Corp., of Gaithersburg, a biotechnology company that manufactures and markets tests for diseases afflicting primarily women, reported net income for its fiscal third quarter ended March 31 of $1.6 million, or 8 cents per diluted share, on revenue of $29.7 million, versus net income of $2.5 million, or 12...
Digene Corporation [DIGE] Chairman & CEO to Ring The NASDAQ Stock Market Opening Bell
What:
MD-based Digene Corp. launching ad campaign to educate women on
The Gaithersburg company that makes the only approved test for the virus that causes cervical cancer is taking its message out of doctors' offices and into homes nationwide.
MD-based Digene Corp. reports net income of $300K
Digene Corp., of Gaithersburg, a biotechnology company that manufactures and markets tests for diseases afflicting primarily women, reported net income for its fiscal second quarter ended Dec. 31 of $300,000, or 1 cent per diluted share, on revenue of $27 million, versus net income of $900,000, or 5 cents per...
All Star Analysts Portfolio highlights: Bank of America Corporation, Commercial Capital Bancorp and Digene Corporation
CHICAGO -- Zacks.com just released its latest additions and deletions to its proprietary All Star Analyst portfolio. Members on this exclusive list are Bank of America Corporation (NYSE:BAC), Commercial Capital Bancorp, Inc. (NASDAQ:CCBI) and Digene Corporation (NASDAQ:DIGE). View the entire list of stocks on the All Star Analyst portfolio at...
All Star Analysts Portfolio Highlights: Digene Corporation, Lowe's Cos., Nextel Communications, and Wells Fargo
CHICAGO -- Zacks.com just released its latest additions and deletions to the coveted All Star Analyst portfolio. This exclusive portfolio represents all stocks with a Strong Buy rating from at least five analysts with a 5 Star All Star ranking. These are the brokerage analysts whose stock recommendations proved to...
- Next »
- page 1 of 2
- « Previous
Sort byClose
Industry Transcripts by Seeking Alpha
-
Indevus Pharmaceuticals, Inc. F4Q08 (Qtr End 09/30/08) Earnings Call Transcript
on Nov 25, 2008about IDEV
-
Noven Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
on Nov 24, 2008about NOVN
-
XenoPort, Inc. Q3 2008 Earnings Call Transcript
on Nov 24, 2008about XNPT
-
Repligen Corporation F2Q09 (Qtr End 09/30/08) Earnings Call Transcript
on Nov 24, 2008about RGEN
-
Omrix Biopharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
on Nov 24, 2008about OMRI
Digene Corp. Company Info
NAICS Code
In-Vitro Diagnostic Substance Manufacturing: 325413
